FARSA, Oldřich, Veronika BALLAYOVÁ, Radka ŽÁČKOVÁ and Peter ZUBÁČ. Aminopeptidase N as a potential drug target. In Ladislav Habala. 51st Conference Synthesis and Analsis of Drugs, Book of Abstracts. 1st ed. Bratislava: Faculty of Pharmacy, Comenius University in Bratislava, 2023, p. 13-13, 55 pp. ISBN 978-80-280-0324-1.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Aminopeptidase N as a potential drug target
Name in Czech Aminopeptidasa N jako potenciální cíl léčiv
Authors FARSA, Oldřich (203 Czech Republic, belonging to the institution), Veronika BALLAYOVÁ (703 Slovakia, belonging to the institution), Radka ŽÁČKOVÁ (203 Czech Republic, belonging to the institution) and Peter ZUBÁČ (703 Slovakia, belonging to the institution).
Edition 1st ed. Bratislava, 51st Conference Synthesis and Analsis of Drugs, Book of Abstracts, p. 13-13, 55 pp. 2023.
Publisher Faculty of Pharmacy, Comenius University in Bratislava
Other information
Original language English
Type of outcome Proceedings paper
Field of Study 30107 Medicinal chemistry
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
Publication form printed version "print"
RIV identification code RIV/00216224:14160/23:00133772
Organization unit Faculty of Pharmacy
ISBN 978-80-280-0324-1
Keywords (in Czech) aminopeptidasa N; inhibitory; protináorová aktivita; antiinfekční aktivita
Keywords in English aminopeptidase N; inhibitors; antitumor activity; anti-infectious activity
Tags International impact
Changed by Changed by: Mgr. Daniela Černá, učo 489184. Changed: 4/4/2024 19:25.
Abstract
Aminopeptidase N is introduced as an enzyme and a therapeutic target, the importance of its inhibitors as potential drugs is summarized, and the contribution of the authors and their institutions to the development of these inhibitors is presented with examples.
Abstract (in Czech)
Aminopeptidasa N je představena jako enzym a terapeutický cíl, shrnut význam jejích inhibitorů jako potenciálních léčiv, a na příkladech představen podíl autorů a jejich pracoviště na vývoji těchto inhibitorů.
Links
EF19_073/0016943, research and development projectName: Interní grantová agentura Masarykovy univerzity
MUNI/A/1682/2020, interní kód MUName: Návrh, syntéza a hodnocení derivátů skupin léčiv s inhibiční enzymatickou aktivitou
Investor: Masaryk University
MUNI/IGA/0932/2021, interní kód MUName: Basic ketones and their derivatives as potential anti-infective and anti-tumor drugs
Investor: Masaryk University
PrintDisplayed: 7/9/2024 12:08